DJIA 17,776.91 93.33 0.53%
NASDAQ 4,997.46 5.52 0.11%
S&P 500 2,081.34 12.58 0.61%
market minute promo


2.29 -0.02 (-0.87%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

VVUS $2.29 -0.87%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.30
Previous Close $2.31
Daily Range $2.23 - $2.31
52-Week Range $2.22 - $5.28
Market Cap $237.7M
P/E Ratio -2.89
Dividend (Yield) $0.00 (0.0%)
Volume 1,006,696
Average Daily Volume 936,439
Current FY EPS -$0.83




Drug Makers

VIVUS, Inc. (VVUS) Description

A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products. Website:

News & Commentary

Obesity Statistics Take a Wrong Turn in This Latest Study

Obesity, the silent killer, costs the global economy $2 trillion annually. Find out what tactics could be used to help curb rising obesity levels.

Orexigen: Contrave Sales Win The Week, Pace Still Slower Than Needed

Arena - Belviq Sales Slide Again

Vivus- Qsymia Sales Dip And Flatten Out

Novo Nordisk: Anti-Obesity Treatment Saxenda Passes 1,000 Scripts

Benzinga's Top #PreMarket Gainers

Orexigen: Contrave Sales Lead The Sector, But Need Improvement

Belviq Sales Remain Flat- Quarter Over Quarter Will Not Impress

The Anti-Obesity Sector In Q2 Is Not Looking Good

Vivus: Something You Would Want To Know About Qsymia

See More VVUS News...

VVUS's Top Competitors

VVUS $2.29 (-0.87%)
Current stock: VVUS
JNJ $98.92 (0.73%)
Current stock: JNJ
NVS $99.17 (0.56%)
Current stock: NVS
RHHBY $35.03 (-0.19%)
Current stock: RHHBY